Palestrante: Dr. Álvaro Avezum - CRM: 61190-SP | |
Palestrante: Dra. Ariane Vieira Scarlatelli Macedo - CRM: 106624-SP | |
Palestrante: Dr. Felix José Alvarez Ramires - CRM: 67397-SP | |
Palestrante: Dra. Fernanda Marciano Consolim-Colombo - CRM: 55219-SP | |
Palestrante: Dr. Henrique Barbosa Ribeiro - CRM: 115727-SP | |
Palestrante: Dr. Marcelo José de Carvalho Cantarelli - CRM: 55879-SP
| |
Moderador: Dr. Miguel Antonio Moretti - CRM: 59352-SP
|
19h00 |
|
19h10 |
|
19h20 | Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results of IMPROVE-HCM Dr. Felix Jose Alvarez Ramires |
19h30 | Preventing Cardiac Damage in Patients Treated For Breast Cancer and Lymphoma: A Phase 3 Randomized, Open Label, Blinded Endpoint, Superiority Trial of Enalapril to Prevent Anthracycline-induced Cardiotoxicity (PROACT) Dra. Ariane Vieira Scarlatelli Macedo |
19h40 | Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients at Low to Intermediate Risk: One Year Outcomes of the Randomized DEDICATE-DZHK6 Trial Dr. Henrique Barbosa Ribeiro |
19h50 | Intravascular Ultrasound-guided Versus Angiography-guided Percutaneous Coronary Intervention in Acute Coronary Syndromes: The Multicenter, Randomized, Blinded, IVUS-ACS Trial Dr. Marcelo José de Carvalho Cantarelli |
20h00 | Discussão e perguntas - Dr. Miguel Antonio Moretti |